NCH Capital

Lexington Partners is a leading global alternative investment manager primarily involved in providing liquidity solutions to owners of private equity Lexington Partners is a leading global alternative investment manager primarily involved in providing liquidity solutions to owners of private equity and other alternative investments and in making co-investments alongside leading private equity sponsors. Lexington Partners is one of the largest independent managers of secondary acquisition and co-investment funds with $52 billion in committed capital since inception. Lexington has acquired over 3,400 secondary and co-investment interests through more than 900 transactions with a total value in excess of $62 billion, including $15 billion of syndications. Lexington also invests in private investment funds during their initial formation and has committed to more than 500 new funds in the U.S., Europe, Latin America, and the Asia-Pacific region. Lexington has offices strategically located in major centers for private equity and alternative investing ‐ New York, Boston, Menlo Park, London, Hong Kong, Santiago, São Paulo and Luxembourg. Lexington also has senior advisors covering Asia, Australia, and the United States.

Founded in 1991, Behrman Capital is a private equity investment firm with more than $2.0 billion of capital under management. The firm invests in the management buyout, leveraged buildup and recapitalization of established growth companies. Behrman Capital specializes in the health care, defense, specialty manufacturing, business-to-business outsourcing and information technology industries. It partners with various institutions, including The National Geographic Society, BankAmerica, the Bank of Nova Scotia, AXA, Partners Group, Hamilton Lane Fund of Funds, Illinois State Board and Wilshire Associates. Behrman Capital makes investments in Ark Holding Company, Athena Diagnostics, Esoterix, Tandem Health Care, and Wil Research Laboratories.